CTSB and breast cancer: In addition, a transgenic mouse model of mammary cancer characterized by loss of hormone receptors with progression of disease [50] exhibited both reduced primary tumor growth and lung metastases when deficient in cathepsin B [51], suggesting a link between cathepsin B expression and/or activity and invasive and metastatic breast disease.